Correction to: Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan.

Authors :: Takeuchi T
Tanaka Y
Tanaka S
Kawakami A
Song YW
Chen YH
Rokuda M
Izutsu H
Ushijima S
Kaneko Y
Nakashima Y
Shiomi T
Yamada E
Source :: Arthritis research & therapy [Arthritis Res Ther] 2020 Jun 23; Vol. 22 (1), pp. 155. Date of Electronic Publication: 2020 Jun 23.
Publication Year :: 2020
Abstract: An amendment to this paper has been published and can be accessed via the original article.

Full Text Access

Tools